Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,035 CAD | +16,67 % | -.--% | -12,50 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
John Campbell
CEO | Chief Executive Officer | 53 | 26/11/20 |
Lyle Oberg
FOU | Founder | 63 | 06/07/18 |
Founder | 65 | 06/07/18 | |
Lih-Ming Tam
DFI | Director of Finance/CFO | - | - |
Chief Operating Officer | - | 09/03/22 | |
Iryna Saranchova
CTO | Chief Tech/Sci/R&D Officer | - | 15/05/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 65 | 06/07/18 | |
Lyle Oberg
FOU | Founder | 63 | 06/07/18 |
John Campbell
CEO | Chief Executive Officer | 53 | 26/11/20 |
Director/Board Member | 61 | 26/11/20 | |
Scott L. Nicoll
BRD | Director/Board Member | - | 28/10/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 24 358 625 | 9 785 852 ( 40,17 %) | 0 | 40,17 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-12,50 % | 1,05 M | |
-3,46 % | 102 mil M | |
+1,41 % | 96,29 mil M | |
+2,13 % | 22,18 mil M | |
-15,84 % | 21,2 mil M | |
-9,21 % | 18,31 mil M | |
-39,98 % | 17,38 mil M | |
-14,65 % | 16,36 mil M | |
+4,39 % | 13,97 mil M | |
+31,35 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción MYND
- Empresa MYND Life Sciences Inc.